122 related articles for article (PubMed ID: 10595380)
1. Medical economic considerations of coronary stenting.
Szucs TD
Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
[TBL] [Abstract][Full Text] [Related]
3. Coronary stenting: costly or cost-effective?
Cohen DJ; Baim DS
J Invasive Cardiol; 1995; 7 Suppl A():36A-42A. PubMed ID: 10155115
[TBL] [Abstract][Full Text] [Related]
4. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
Ikeda S; Bosch J; Banz K; Schneller P
J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
[TBL] [Abstract][Full Text] [Related]
5. Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
Ijsselmuiden AJ; Tangelder GJ; Cotton JM; Vaijifdar B; Kiemeneij F; Slagboom T; v d Wieken R; Serruys PW; Laarman GJ
Int J Cardiovasc Intervent; 2003; 5(3):143-50. PubMed ID: 12959731
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
7. [Coronary angioplasty: always a stent in arteries larger than 2.5 mm? The arguments con].
Goicolea Ruigómez FJ; Macaya Miguel C
Rev Esp Cardiol; 1999 Feb; 52(2):85-94. PubMed ID: 10073089
[TBL] [Abstract][Full Text] [Related]
8. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
9. Economic impact on physicians and hospitals of proposed changes in Medicare reimbursement for coronary interventions.
Vaitkus PT
Am Heart J; 1999 Feb; 137(2):258-63. PubMed ID: 9924159
[TBL] [Abstract][Full Text] [Related]
10. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
Odell A; Landelius P; Astrom-Olsson K; Grip L
Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of stenting with or without balloon predilation for the treatment of coronary artery disease.
Kovar LI; Monrad ES; Sherman W; Kunchithapatham S; Ravi KL; Gotsis W; Silverman G; Brown DL
Am Heart J; 2001 Nov; 142(5):E9. PubMed ID: 11685184
[TBL] [Abstract][Full Text] [Related]
12. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
13. Shifting the balance: direct stenting a novel approach to improve the cost effectiveness of intra-coronary stenting.
Cotton JM; Kearney MT; Wainwright RJ
Eur Heart J; 2000 Jan; 21(2):170. PubMed ID: 10637091
[No Abstract] [Full Text] [Related]
14. Economics and outcomes of coronary stenting: are stents right for everybody?
Weintraub WS
J Invasive Cardiol; 2000 Apr; 12(4):200-2. PubMed ID: 10785673
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
[TBL] [Abstract][Full Text] [Related]
16. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.
Cohen DJ; Krumholz HM; Sukin CA; Ho KK; Siegrist RB; Cleman M; Heuser RR; Brinker JA; Moses JW; Savage MP
Circulation; 1995 Nov; 92(9):2480-7. PubMed ID: 7586348
[TBL] [Abstract][Full Text] [Related]
17. Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.
Weintraub WS; Warner CD; Mauldin PD; Becker ER; Gomes D; Cook J; Kosinski A; Boccuzzi S
Am J Manag Care; 1997 May; 3(5):743-9. PubMed ID: 10169536
[TBL] [Abstract][Full Text] [Related]
18. Review of recent US cost estimates of revascularization.
Nagle PC; Smith AW
Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and economic aspects of chronic coronary restenosis: potential advantage of intracoronary brachytherapy].
Schiele TM; Siebert U; Cohen D; Klauss V
Dtsch Med Wochenschr; 2001 Apr; 126(15):440-4. PubMed ID: 11347008
[No Abstract] [Full Text] [Related]
20. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
